X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17267) 17267
Book Chapter (149) 149
Dissertation (25) 25
Book / eBook (22) 22
Conference Proceeding (17) 17
Government Document (17) 17
Publication (14) 14
Magazine Article (6) 6
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11734) 11734
oncology (9167) 9167
female (6674) 6674
cancer (5032) 5032
metastatic breast-cancer (4839) 4839
middle aged (4110) 4110
chemotherapy (4040) 4040
metastasis (3855) 3855
breast cancer (3790) 3790
aged (3614) 3614
adult (3230) 3230
male (3049) 3049
metastatic breast cancer (3025) 3025
animals (2884) 2884
breast neoplasms - drug therapy (2384) 2384
breast neoplasms - pathology (2345) 2345
care and treatment (2206) 2206
tumors (2145) 2145
survival (2029) 2029
treatment outcome (1922) 1922
neoplasm metastasis (1814) 1814
research (1796) 1796
prognosis (1795) 1795
breast-cancer (1792) 1792
pharmacology & pharmacy (1788) 1788
therapy (1753) 1753
medicine & public health (1710) 1710
antineoplastic combined chemotherapy protocols - therapeutic use (1678) 1678
antineoplastic agents - therapeutic use (1631) 1631
metastatic colorectal-cancer (1622) 1622
metastatic melanoma (1585) 1585
trastuzumab (1492) 1492
analysis (1453) 1453
aged, 80 and over (1448) 1448
neoplasms - drug therapy (1381) 1381
mice (1351) 1351
cell line, tumor (1261) 1261
health aspects (1259) 1259
cell lung-cancer (1249) 1249
immunotherapy (1247) 1247
expression (1205) 1205
metastases (1191) 1191
melanoma (1137) 1137
cancer therapies (1129) 1129
cell biology (1039) 1039
phase-ii trial (1025) 1025
patients (1016) 1016
carcinoma (1001) 1001
paclitaxel (999) 999
monoclonal-antibody (996) 996
clinical trials (974) 974
phase-ii (956) 956
drug therapy (937) 937
disease-free survival (933) 933
surgery (932) 932
review (889) 889
medicine, research & experimental (885) 885
docetaxel (863) 863
development and progression (844) 844
immunology (841) 841
trial (835) 835
retrospective studies (827) 827
neoplasm staging (818) 818
cancer research (808) 808
neoplasms - therapy (780) 780
bevacizumab (771) 771
antineoplastic combined chemotherapy protocols - adverse effects (769) 769
disease progression (769) 769
antineoplastic agents - pharmacology (762) 762
hematology, oncology and palliative medicine (759) 759
immunohistochemistry (755) 755
survival analysis (755) 755
pathology (753) 753
biochemistry & molecular biology (730) 730
receptor, erbb-2 - metabolism (726) 726
neoplasms - pathology (724) 724
breast neoplasms - metabolism (723) 723
clinical trials as topic (712) 712
diagnosis (712) 712
colorectal cancer (705) 705
apoptosis (703) 703
metastatic (699) 699
breast neoplasms - mortality (683) 683
biomarkers (679) 679
gene expression (678) 678
survival rate (676) 676
capecitabine (675) 675
combination (671) 671
lung-cancer (670) 670
mutation (666) 666
angiogenesis (664) 664
medical research (664) 664
antibodies, monoclonal - therapeutic use (653) 653
antineoplastic agents - adverse effects (650) 650
proteins (650) 650
her2 (642) 642
medicine (641) 641
efficacy (638) 638
medical prognosis (634) 634
antineoplastic agents (626) 626
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16996) 16996
French (219) 219
German (164) 164
Japanese (109) 109
Russian (52) 52
Spanish (50) 50
Polish (30) 30
Korean (19) 19
Italian (18) 18
Portuguese (13) 13
Chinese (11) 11
Czech (9) 9
Turkish (7) 7
Hungarian (4) 4
Norwegian (2) 2
Slovenian (2) 2
Swedish (2) 2
Dutch (1) 1
Hebrew (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature cell biology, ISSN 1476-4679, 2016, Volume 18, Issue 2, pp. 213 - 224
Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement... 
TARGET | HIF-1 | PROTEIN | LONG NONCODING RNAS | TYROSINE KINASE | EPIGENETIC REGULATION | BINDING SITES | HYPOXIA | TUMOR-GROWTH | PROMOTES | CELL BIOLOGY | Heparin-binding EGF-like Growth Factor - pharmacology | Phosphorylation | Prognosis | Membrane Glycoproteins - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Multiprotein Complexes | Serine | Gene Expression Regulation, Neoplastic | Proline | Cytoplasm - metabolism | E1A-Associated p300 Protein - metabolism | Neoplasm Proteins - metabolism | Transfection | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Triple Negative Breast Neoplasms - pathology | Female | Transcription, Genetic | Protein Stability | Protein-Serine-Threonine Kinases - metabolism | Tyrosine | ErbB Receptors - metabolism | Hydroxylation | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | RNA, Long Noncoding - genetics | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Animals | Triple Negative Breast Neoplasms - genetics | Signal Transduction - drug effects | Mice, Nude | Cell Line, Tumor | Glycolysis | RNA, Long Noncoding - metabolism | Index Medicus | glycoprotein non-metastatic b (GPNMB) | Epidermal Growth Factor Receptor (EGFR) | Triple-negative Breast Cancer (TNBC) | Long Noncoding RNA | Signaling Transduction | Glycolysis Reprogramming | HIF1α
Journal Article
Annals of oncology, ISSN 0923-7534, 2018, Volume 29, Issue 8, pp. 1634 - 1657
Journal Article
Breast cancer research and treatment, ISSN 1573-7217, 2013, Volume 143, Issue 3, pp. 459 - 467
Journal Article
Journal Article
by Xin Jin and Ping Mu
Breast cancer : basic and clinical research, ISSN 1178-2234, 12/2015, Volume 9s1, Issue S1, pp. BCBCR.S25460 - 34
Metastasis is the leading cause of breast cancer-associated deaths. Despite the significant improvement in current therapies in extending patient life, 30–40... 
Breast cancer | Metastasis | Precision medicine | Metastatic traits | Targeted therapy
Journal Article